Key result
Higher angiopoietin-2 levels are found in AKI patients, and a higher angiopoietin-1 to angiopoietin-2 ratio may be linked with a reduced risk of CKD progression.
Why the study?
Renal injury is a leading cause of morbidity and mortality, but reliable indicators for determining the likelihood of developing CKD, CKD progression, or AKI events are lacking.
Can angiopoietin-2 levels serve as a prognostic marker for AKI and CKD progression?
Can angiopoietin-2 levels serve as a prognostic marker for AKI and CKD progression?
Angiopoietin-2 may serve as an important prognostic biomarker for predicting AKI and CKD progression, though large-scale clinical trials are needed to confirm its clinical utility.
No takes yet. Share an insight, caveat, or question.
Ang-2 elevation may aid post-AKI risk stratification; leaves open whether pathway targeting alters CKD progression in trials.
Yıldız et al. (2024) conducted a review in Kidney Disease. Angiopoietin-2 was evaluated on AKI and CKD progression. Higher angiopoietin-2 levels are found in AKI patients, and a higher angiopoietin-1 to angiopoietin-2 ratio may be linked with a reduced risk of CKD progression.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: